Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Warner

Showing results (11-20 of 159) with videos related to

Pageof 16
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2020
Does adding local salvage ablation therapy provide survival advantage for patients with locally recurrent prostate cancer following radiotherapy? Whole gland salvage ablation post-radiation failure in prostate cancerShiva Madhwan Nair, Andrew Warner, Arnon Lavi, et al.
Cureus|September 2, 2024
Impact of the COVID-19 Pandemic on Academic Productivity in Oncology: A Journal-, Conference- and Author-Level AnalysisVivian S Tan, Andrew Warner, Anthony C Nichols, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
The Elevated Expression of ORF75, a Lytic KSHV Gene, in Kaposi Sarcoma Lesions is Driven by a GC-rich DNA cis Element in its Promoter RegionAshwin Nair, David A Davis, Andrew Warner, et al.
Current Oncology (Toronto, Ont.)|October 22, 2021
The Influence of Adjuvant Chemotherapy Dose Intensity on Five-Year Outcomes in Resected Colon Cancer: A Single Centre Retrospective AnalysisSuganija Lakkunarajah, Daniel A Breadner, Hanbo Zhang, et al.
Plos Pathogens|March 17, 2025
The elevated expression of ORF75, a KSHV lytic gene, in Kaposi sarcoma lesions is driven by a GC-rich DNA cis element in its promoter regionAshwin Nair, David A Davis, Andrew Warner, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 15, 2023
<sup>18</sup>F-DCFPyL PSMA-PET affects management of salvage radiotherapy for post-prostatectomy patients with biochemical failure: A matched cohort studyAndrew J Arifin, Stephanie Gulstene, Andrew Warner, et al.
Advances in Radiation Oncology|November 2, 2019
Does 5 + 5 Equal Better Radiation Treatment Plans in Head and Neck Cancers?Mark T Corkum, Sylvia Mitchell, Varagur Venkatesan, et al.
Journal of Applied Clinical Medical Physics|June 1, 2026
Investigating Setup Error Differences between Conventional and Ultra-Hypofractionated Whole Pelvis Radiation Therapy: A Secondary Analysis from the HOPE Randomized Clinical TrialBryan Schaly, Lucas C Mendez, Maha Khawaja, et al.
Human Molecular Genetics|February 28, 2007
Cellular and molecular studies of Marfan syndrome mutations identify co-operative protein folding in the cbEGF12-13 region of fibrillin-1Pat Whiteman, Antony C Willis, Andrew Warner, et al.
BMC Palliative Care|December 9, 2022
DART: diagnostic-CT-enabled planning: a randomized trial in palliative radiation therapy (study protocol)Melissa O'Neil, Timothy K Nguyen, Joanna Laba, et al.
Pageof 16

Showing results (11-20 of 159) with videos related to

Sort By:
Pageof 16
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2020
Does adding local salvage ablation therapy provide survival advantage for patients with locally recurrent prostate cancer following radiotherapy? Whole gland salvage ablation post-radiation failure in prostate cancerShiva Madhwan Nair, Andrew Warner, Arnon Lavi, et al.
Cureus|September 2, 2024
Impact of the COVID-19 Pandemic on Academic Productivity in Oncology: A Journal-, Conference- and Author-Level AnalysisVivian S Tan, Andrew Warner, Anthony C Nichols, et al.
Biorxiv : the Preprint Server for Biology|October 1, 2025
The Elevated Expression of ORF75, a Lytic KSHV Gene, in Kaposi Sarcoma Lesions is Driven by a GC-rich DNA cis Element in its Promoter RegionAshwin Nair, David A Davis, Andrew Warner, et al.
Current Oncology (Toronto, Ont.)|October 22, 2021
The Influence of Adjuvant Chemotherapy Dose Intensity on Five-Year Outcomes in Resected Colon Cancer: A Single Centre Retrospective AnalysisSuganija Lakkunarajah, Daniel A Breadner, Hanbo Zhang, et al.
Plos Pathogens|March 17, 2025
The elevated expression of ORF75, a KSHV lytic gene, in Kaposi sarcoma lesions is driven by a GC-rich DNA cis element in its promoter regionAshwin Nair, David A Davis, Andrew Warner, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|August 15, 2023
<sup>18</sup>F-DCFPyL PSMA-PET affects management of salvage radiotherapy for post-prostatectomy patients with biochemical failure: A matched cohort studyAndrew J Arifin, Stephanie Gulstene, Andrew Warner, et al.
Advances in Radiation Oncology|November 2, 2019
Does 5 + 5 Equal Better Radiation Treatment Plans in Head and Neck Cancers?Mark T Corkum, Sylvia Mitchell, Varagur Venkatesan, et al.
Journal of Applied Clinical Medical Physics|June 1, 2026
Investigating Setup Error Differences between Conventional and Ultra-Hypofractionated Whole Pelvis Radiation Therapy: A Secondary Analysis from the HOPE Randomized Clinical TrialBryan Schaly, Lucas C Mendez, Maha Khawaja, et al.
Human Molecular Genetics|February 28, 2007
Cellular and molecular studies of Marfan syndrome mutations identify co-operative protein folding in the cbEGF12-13 region of fibrillin-1Pat Whiteman, Antony C Willis, Andrew Warner, et al.
BMC Palliative Care|December 9, 2022
DART: diagnostic-CT-enabled planning: a randomized trial in palliative radiation therapy (study protocol)Melissa O'Neil, Timothy K Nguyen, Joanna Laba, et al.
Pageof 16